Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin and Lorcaserin for Weight Loss in Schizophrenia

NCT02796144 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT02796144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02796144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin and Lorcaserin for Weight Loss in Schizophrenia
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2016
Completion date
February 14, 2020
Enrollment
71 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

overweight, schizoaffective disorder, schizophrenia